This large cohort study examines long-term trends and predictors of viremia among pregnant and postpartum adolescent girls and young women (AGYW) living with human immunodeficiency virus (HIV) in Tanzania. This prospective cohort study included 7703 pregnant/postpartum AGYW with at least one viral load (VL) enrolled in routine prevention of mother-to-child transmission (PMTCT) care between 2018 and 2020 across three regions in Tanzania and followed for a minimum of 36 months. Poisson generalized linear models with a log link function were used to estimate adjusted incidence rate ratios and 95% confidence intervals for detectable viremia (VL ≥50 copies/mL) by baseline exposures. Over three years, detectable viremia was highest among the youngest age group 15-17 years (20.4%) compared with those aged 18-19 (16.7%) and 20-24 years (12.5%). Viremia declined during pregnancy but plateaued postpartum, with >10% of participants remaining viremic. Perinatally infected AGYW (HIV diagnosis at age ≤12 years) had higher rates of viremia (28.8%) than those already receiving antiretroviral therapy (ART) (11.0%) or newly initiated on ART (15.2%) who were diagnosed after childhood. Over 25% of perinatally infected AGYW remained viremic throughout the PMTCT cycle. Second-line ART and urban residence were associated with higher risk of viremia. Persistently high viremia was observed over time among Tanzanian pregnant/postpartum AGYW with HIV, particularly adolescents and those with perinatally acquired infection. Tailored PMTCT interventions, including resistance-informed treatment and youth-friendly adherence support, are needed to improve maternal outcomes and accelerate elimination of vertical transmission.
Background: Adolescent girls and young women (AGYW) aged 15-24 contribute a large share of vertical HIV transmission to infants due to gaps in programs for the prevention of mother-to-child transmission of HIV (PMTCT). This large cohort study examines long-term trends and predictors of viremia among pregnant and postpartum AGYW living with HIV in Tanzania. Methods: This prospective cohort study of 10417 pregnant/postpartum AGYW enrolled in routine HIV/PMTCT care between 2018 and 2020 at 543 facilities across three regions of Tanzania included all 7703 AGYW with at least one viral load (VL) over a minimum of 36 months of follow-up. Generalized Linear Models (Poisson with log link) estimated adjusted incident rate ratios (aIRR) and 95% confidence intervals (CIs) for detectable viremia (VL≥50 copies/mL) in relation to baseline exposures. Findings: Over three years of follow-up, the average proportion with detectable viremia was significantly higher among the youngest aged 15-17 (20.4%), compared to those aged 18–19 (16·7%) and 20–24 years (12·5%). The proportion of viremic AGYW halved during pregnancy, but then stagnated after delivery, with over 10% remaining viremic throughout postpartum. Perinatally infected AGYW (HIV diagnosis before age ≤12 years) had a significantly higher rate of viremia (28·8%) compared to both AGYW on ART (11·0%) and new on ART (15·2%) who were diagnosed after childhood. Over 25% of perinatally infected AGYW remained viremic throughout the PMTCT cycle, indicating treatment failure, likely resistance, and persistent adherence problems. Second-line regimen and urban residency were independently associated with a higher risk of viremia. Interpretation: HIV viremia during pregnancy and postpartum among Tanzanian AGYW remains a major challenge, particularly among adolescents and those with perinatally acquired HIV. Tailored PMTCT interventions such as resistance-informed treatment optimization and youth-friendly age-responsive adherence support are necessary to improve maternal outcomes and accelerate elimination of vertical HIV transmission for young mothers.